GNH USA

Europe — EMA

Memantin Stada

GNH USA supplies Memantin Stada (Memantine), a NMDA receptor antagonist for moderate to severe Alzheimer's disease. Request a quote for global supply.

Memantine

Request sourcing

1
Pack/s

What is Memantine?

Memantine, the active ingredient in Memantin Stada, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to improve cognition and daily functioning.

GNH USA supplies Memantin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

What is Memantine used for?

Memantin Stada is used in the management of Alzheimer’s disease, targeting the glutamatergic pathway to mitigate neurodegeneration.

- Alzheimer’s disease (moderate to severe): improves cognition, memory, and daily functional abilities. - Alzheimer’s disease (mild to moderate) when combined with a cholinesterase inhibitor: may enhance overall therapeutic benefit. - Behavioral symptoms of Alzheimer’s disease: can help reduce agitation and aggression.

What are the side effects of Memantine?

Memantin Stada may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion

Serious or Rare Side Effects: - Severe allergic reactions (e.g., rash, swelling, difficulty breathing) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Seizures - Hallucinations or psychotic symptoms

What precautions apply to Memantine?

When prescribing Memantin Stada, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: assess kidney function and adjust dose as needed. - History of seizures: monitor for increased seizure activity. - Cardiovascular disease: observe blood pressure and heart rate regularly. - Concomitant use with other NMDA antagonists: avoid combined therapy to reduce neurotoxicity risk. - Pregnancy and breastfeeding: safety unknown; use only if potential benefit justifies the risk. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Memantine interact with?

Memantin Stada can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neuropsychiatric side effects. - Ketamine: combined NMDA blockade can lead to excessive CNS depression. - Other NMDA receptor antagonists: heightened risk of neurotoxicity.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: memantine may potentiate blood‑pressure‑lowering effects. - Diuretics: increased risk of dehydration and electrolyte imbalance. - Anticholinergic drugs: may worsen cognitive impairment.

Frequently asked questions

What is Memantin Stada used for?+
Memantin Stada contains memantine, which is approved for the treatment of moderate to severe Alzheimer’s disease. It helps to improve cognitive function, memory, and the ability to perform daily activities in adult patients diagnosed with this form of dementia.
How does memantine work?+
Memantine works by blocking the NMDA (N‑methyl‑D‑aspartate) receptor in the brain. This non‑competitive antagonism reduces excessive calcium influx caused by prolonged glutamate activity, limiting excitotoxic neuronal damage while preserving normal synaptic signaling.
What is the usual dose of Memantin Stada?+
The dosing regimen for Memantin Stada is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. The prescriber will typically start with a low dose and titrate upward as needed.
Is Memantin Stada safe in pregnancy or breastfeeding?+
Safety data for memantine during pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, so it should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant.
How do I order Memantin Stada from GNH USA?+
To order Memantin Stada, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.
How does Memantin Stada compare with the main alternative drug class?+
The primary alternative class for Alzheimer’s disease is cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine modulates glutamate‑mediated excitotoxicity. Memantine is typically used in moderate to severe disease or in combination with a cholinesterase inhibitor to provide complementary mechanisms of action.
How should Memantin Stada be stored and handled?+
Memantin Stada tablets should be stored at room temperature, below 25 °C, in the original blister pack. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability throughout its shelf life.
How is Memantin Stada administered?+
Memantin Stada is taken orally. The tablet should be swallowed whole with water, with or without food, as directed by the prescriber. Patients should follow the titration schedule provided by their healthcare professional.
What are the most serious risks to watch for while taking Memantin Stada?+
Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), Stevens‑Johnson syndrome or toxic epidermal necrolysis, seizures, and new or worsening hallucinations or psychotic symptoms. Any of these events require immediate medical attention.
Who should not use Memantin Stada?+
Memantin Stada should be avoided in patients with known hypersensitivity to memantine or any excipients, in those with severe renal impairment without dose adjustment, and in individuals taking other NMDA antagonists where additive neurotoxicity could occur. Clinicians should evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Memantine
Route
Oral Use
Manufacturer
Stada Arzneimittel Ag
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU